Aricept (donepezil hydrochloride) NDC 62856-247

NDC codes

FDA NDC Directory

Product NDC (as listed)62856-247Labeler and product segments. Claims need a package NDC.

Product NDC at billing width62856-0247Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
62856-247-30	62856024730	30 TABLET, FILM COATED in 1 BOTTLE (62856-247-30)Marketed from Jul 23, 2010

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Aricept
Generic name (nonproprietary): donepezil hydrochloride
Active ingredients: Donepezil hydrochloride — 23 mg/1
Dosage form: Tablet, Film coated
Route: Oral
Labeler: Eisai Inc.
Product type: Prescription drug
Marketing category: NDA — New Drug ApplicationApplication NDA 022568
Marketing start: Jul 23, 2010
Listing expires: Dec 31, 2027
Other FDA classes: Cholinesterase Inhibitors (Mechanism)
Identifiers: Product ID 62856-247_91e2ba56-4fdb-4f6f-bff1-30967a410987SPL ID 91e2ba56-4fdb-4f6f-bff1-30967a410987SPL set ID 98e451e1-e4d7-4439-a675-c5457ba20975RxCUI 997220, 997222, 997223, 997224, 997226, 997228, 997229, 997230, 1100184, 1100187UNII 3O2T2PJ89DUPC 0362856245302, 0362856247306, 0362856246309
Pharmacologic class: Cholinesterase Inhibitor

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N462856024730 followed by a unit qualifier and the quantity

Package 62856-0247-30. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Dec 30, 2021.

Indications (excerpt from the label)

ARICEPT is indicated for the treatment of dementia of the Alzheimer’s type. Efficacy has been demonstrated in patients with mild, moderate, and severe Alzheimer’s disease. ARICEPT is an acetylcholinesterase inhibitor indicated for the treatment of dementia of the Alzheimer’s type. Efficacy has been demonstrated in patients with mild, moderate, and severe Alzheimer’s Disease ( 1 )

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)